The second Science to Market Conference took place in Hannover, Germany, on October 6 – 7, 2009. The aim of the conference was the promotion of cooperation between academia and industry in the area of pharmaceutical biotechnology.
The Steinbeis-Europa-Zentrum receives funding to build a network for "Bio-active plant ingredients” in Baden-Wuerttemberg from the "Central Innovation programme SME - ZIM" under the funding module NEMO of the Federal Ministry of Economics and Technology. BIOPRO Baden-Wuerttemberg GmbH supports the network as one of the partners.
The German Network for Bioinformatics Infrastructure, de.NBI for short, is a successful model for infrastructures in the life sciences and biomedicine that is currently being expanded. The network, which was established in 2015, will benefit from more hardware, more staff, more projects and its own cloud. It has also joined the European ELIXIR network.
With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding new cooperation partners.
The University of Tübingen is optimising its drug development pipeline. The TuCADD consortium provides professional help to people who want to take potential drug candidates to clinical application. The coaching involves assistance with the entire phase I drug development phase from industry experts.
The Bioactive Plant Foods network which is coordinated by the Steinbeis-Europa-Zentrum in Stuttgart is focused on developing innovative products that have a positive effect on human health and placing them on the market. Research resolves around the health-promoting effect of amaranth a short-lived plant with catkin-like cymes of densely packed red flowers. More than 20 partners from industry science and marketing have been working together since 2010 to advance the issue of biological activity and health. The coordinator of the network Hartmut Welck provides insights into this sector in Baden-Württemberg the successes that have been achieved by network partners and why the network is particularly focussing on amaranth.
It is also in the interest of small companies to look beyond their national borders: biotechnology and medical technology specialists in neighbouring European countries offer excellent prospects to German companies – and vice versa. Regional life sciences networks help establish and intensify contacts and collaborative activities between international partners.
Dietary supplements support a well-balanced diet and lifestyle. Anoxymer GmbH develops health-enhancing plant extracts that contribute to healthy nutrition. With its expertise in using raw materials from South America for the development of botanical extracts and the distribution of its products in Asia, the company is a competent partner in the “Bioactive Plant Foods” network.
VivaCell Biotechnology GmbH offers in vivo and in vitro demonstration of the efficacy of pharmaceutical and phytopharmaceutical compounds and nutraceuticals. Using its specific in vitro and in vivo models, the company has been able to prove the health-enhancing effect of numerous foods, and is thus an excellent partner in the Bioactive Plant Foods Network.
Ten years ago, cellular signalling was a simple and straightforward process. Nowadays, what once seemed so simple is riddled with complexities. Dr. Tilman Brummer and his team at the Centre for Biosystems Analysis (ZBSA) in Freiburg are investigating the complex molecular interactions sparked off by signals inside cells. They are especially interested in the signalling network involving the protein Raf. Faults in the dynamic processes involving the molecule and its numerous interaction partners can lead to cancer. The researchers can only effectively intervene if they know and understand the entire network.
A European network for research into rare inherited metabolic disorders will be coordinated by PD Dr. Stefan Kölker, head of the Division of Inherited Metabolic Diseases at the Centre for Paediatric and Adolescent Medicine, University of Heidelberg. The project, which will initially run for three years, has a financial volume of 1.3 million euros. More than 40 partners from 17 European countries are part of the “European registry and network for intoxication type metabolic diseases (E-IMD)”.
BIOPRO Baden-Württembergs business development activities have led to the establishment of a new distribution partnership between Heidelberg-based Medicyte GmbH and Dutch Westburg BV. When BIOPRO searches for international partners for Baden-Württemberg companies the state agency often makes use of its international network partners and in this case BIOPROs contact with the Netherlands Business Support Office Stuttgart NBSO brought the desired results.
AnDiaTec GmbH & Co. KG from Kornwestheim is in high demand worldwide as a partner specialising in detection methods for bacteria and viruses. The company is a world market leader in real time PCR Kits for the detection of noroviruses. The U.S. Ministry of Agriculture even draws on the expertise of AnDiaTec in relation to virus infections in cattle. After an intensive period of research and development, the company is now expanding its sales network even further. The first contracts have already been signed with pharmaceutical groups.
BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH! e.V., a partner network for new companies founded by academics at Stuttgart universities
BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a sustainable network of companies, institutions and hospitals.
The gastrointestinal tract and its nervous system have numerous functions related to the uptake of food and they also play an important role in the development of adiposity. The Institute of Nutritional Medicine at the University of Hohenheim Germany carries out numerous projects aimed at investigating the relationships between food uptake digestive and nervous systems thus making the institute an excellent partner in the Bioactive Plant Foods network.
BioRegio STERN Management GmbH honoured the winners of the regional “Science2Start” ideas competition on July 21. The three victors from Stuttgart, Tübingen and Reutlingen celebrated their success together with over 300 guests at a joint summer reception organised by BioRegio STERN Management GmbH, PUSH! (the partner network for new companies founded by academics at Stuttgart universities), the Society for the Promotion of Biotechnology and Medical Technology and the University of Hohenheim.
The annual Networking Breakfast was held at the Chicago Club on 23rd April 2013 on the occasion of the 2013 BIO International Convention the global event for biotechnology. As part of the event Heidelberg Technology Park HTP and the University Technology Park in Chicago unveiled an expanded partnering programme. Around 70 participants from 12 countries used the exclusive setting to make new international contacts renew old ones and exchange thoughts on cooperation possibilities.
The objective of the National Cohort study, the largest prospective study ever conducted in Germany, is to provide answers to a broad range of epidemiological questions, to identify risk factors for common diseases and to open up new treatment pathways. This project is being planned since beginning 2009 by the health centers of the Helmholtz Association in a network with partners from universities and other public research institutions.
From informal gatherings to an association and since 1st July 2008 its own office in Constance the BioLAGO life sciences network at Lake Constance hopes that its new premises and organisational remodelling will help in the better and more comprehensive exploitation of the life sciences and biotechnology potential of the entire Lake Constance region.
The process of ageing appears, at least at first sight, to be fairly tangible and is visible both at individual and societal level. Nevertheless, science has not yet come up with detailed insights into the physiology of ageing. Jörg Bergemann, Professor of Biomedical Engineering at the Albstadt-Sigmaringen University of Applied Sciences, is studying the processes of ageing in skin cells in a project that has recently been granted funding by the German Federal Ministry of Education and Research (BMBF). Bergemann almost missed the BMBF’s deadline when one project partner unexpectedly backed out of the project. However, the BioLAGO network stepped in at the last minute to help.
Information obtained in the various projects of the International Cancer Genome Consortium may soon be used to the benefit of cancer patients worldwide because the data will be freely accessible and not patentable. The project thus aims to make sure that the molecular data of the various tumor types can be used as swiftly as possible for new diagnostic methods or therapies.
“capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors.
Seven European research institutions and GATC Biotech have formed a consortium providing cutting-edge training in the scientific study of the human past. The BEAN (Bridging the European and Anatolian Neolithic) Initial Training Network has been awarded four years of funding from the European Commission through the Marie Curie Actions program. It is a new multinational and multidisciplinary Marie Curie Research initiative exploring the origins of European agriculture.
Bioactive substances are the speciality of BioTeSys GmbH an Esslingen-based biotech company. The company works with a range of products including cosmetics plant and berry extracts and low-dosage non-prescription food supplements. BioTeSys investigates the efficacy of the active ingredients of such products as well as the raw materials used to manufacture them.